Mast cells as "tunable" effector and immunoregulatory cells: Recent advances

Annual Review of Immunology

Volumn 23, Issue , 2005, Pages 749-786

  Galli, Stephen J ^a   Kalesnikoff, Janet ^a   Grimbaldeston, Michele A ^a   Piliponsky, Adrian M ^a   Williams, Cara M M ^a   Tsai, Mindy ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired immunity; Allergy; Basophils; Cytokines; Inflammation; Innate immunity; Signaling; Tissue remodeling

Indexed keywords

CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY;

ALLERGY; BASOPHIL; CELL FUNCTION; CELLULAR IMMUNITY; EFFECTOR CELL; ENVIRONMENTAL FACTOR; HEREDITY; IMMUNE RESPONSE; IMMUNITY; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; KINETICS; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ASTHMA; BASOPHILS; DERMATITIS, CONTACT; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MAST CELLS; MICE; MICE, MUTANT STRAINS; MODELS, IMMUNOLOGICAL; RECEPTORS, IGE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 13944277507     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.141025     Document Type: Review

References (205)

1. Kitamura Y. 1989. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol. 7:59-76
2. Metcalfe DD, Baram D, Mekori YA. 1997. Mast cells. Physiol. Rev. 77(4): 1033-79
3. Galli SJ, Lantz CS. 1999. Allergy. In Fundamental Immunology, ed. WE Paul, pp. 1137-84. Philadelphia, PA: Lippincott-Raven
4. Galli SJ, Zsebo KM Geissler EN. 1994. The kit ligand, stem cell factor. Adv. Immunol. 55:1-96
5. Galli SJ, Metcalfe DD, Arber DA, Dvorak AM. 2005. Basophils and mast cells and their disorders. In Williams Hematology, ed. E Beutler, MA Lichtman, BS Coller, TJ Kipps, U Seligsohn. New York: McGraw-Hill. In press
6. Galli SJ. 2000. Mast cells and basophils. Curr. Opin. Hematol. 7(1):32-39
7. Williams CMM, Galli SJ. 2000. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J. Allergy Clin. Immunol. 105(5): 847-59
8. Sayama K, Diehn M, Matsuda K, Lunderius C, Tsai M, et al. 2002. Transcriptional response of human mast cells stimulated via the FcεRI and identification of mast cells as a source of IL-11. BMC Immunol. 3(1):5
9. Nakajima T, Inagaki N, Tanaka H, Tanaka A, Yoshikawa M, et al. 2002. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcε receptor I cross-linking: an interspecies comparison. Blood 100(12):3861-68
10. Okumura S, Kashiwakura J, Tomita H, Matsumoto K, Nakajima T, et al. 2003. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcεRI. Blood 102(7):2547-54
11. Voehringer D, Shinkai K, Locksley RM. 2004. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 20(3):267-77
12. Enerback L, Lowhagen GB. 1979. Long term increase of mucosal mast cells in the rat induced by administration of compound 48/80. Cell Tissue Res. 198(2):209-15
13. Bienenstock J, Befus D, Denburg J, Goto T, Lee T, et al. 1985. Comparative aspects of mast cell heterogeneity in different species and sites. Int. Arch. Allergy Appl. Immunol 77(1-2):126-29
14. Galli SJ. 1990. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62(1):5-33
15. Huang C, Sali A, Stevens RL. 1998. Regulation and function of mast cell proteases in inflammation. J. Clin. Immunol. 18(3):169-83
16. Metzger H. 1992. The receptor with high affinity for IgE. Immunol. Rev. 125:37-48
17. Turner H, Kinet JP. 1999. Signalling through the high-affinity IgE receptor FcεRI. Nature 402(Suppl.):B24-30
18. Kinet JP. 1999. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu. Rev. Immunol. 17:931-72
19. Ott VL, Cambier JC. 2000. Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention? J. Allergy Clin. Immunol. 106(3):429-40
20. Nadler MJ, Matthews SA, Turner H, Kinet JP, et al. 2000. Signal transduction by the high-affinity immunoglobulin E receptor FcεRI: coupling form to function. Adv. Immunol. 76:325-55
21. Kawakami T, Galli SJ. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2(10):773-86
22. Rivera J. 2002. Molecular adapters in FcεRI signaling and the allergic response. Curr. Opin. Immunol. 14(6): 688-93
23. Siraganian RP. 2003. Mast cell signal transduction from the high-affinity IgE receptor. Curr. Opin. Immunol. 15(6): 639-46
24. Blank U, Rivera J. 2004. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol. 25(5):266-73
25. Dvorak AM, Dvorak HF, Karnovsky MJ. 1972. Uptake of horseradish peroxidase by guinea pig basophilic leukocytes. Lab. Invest. 26(1):27-39
26. Dvorak AM. 1992. Basophils and mast cells: piecemeal degranulation in situ and ex vivo: a possible mechanism for cytokine-induced function in disease. Immunol. Ser. 57:169-271
27. Dvorak AM, Tepper RI, Weller PF, Morgan ES, Estrella P, et al. 1994. Piece-meal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice. Evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. Blood 83(12):3600-12
28. Miller HR. 1996. Mucosal mast cells and the allergic response against nematode parasites. Vet. Immunol. Immunopathol. 54(1-4):331-36
29. Wedemeyer J, Tsai M, Galli SJ. 2000. Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immunol. 12(6):624-31
30. Galli SJ. 1997. Complexity and redundancy in the pathogenesis of asthma: reassessing the roles of mast cells and T cells. J. Exp. Med. 186(3):343-47
31. d mast cell-deficient mice. J. Immunol 131(6): 2687-94
32. Biedermann T, Kneilling M, Mailhammer R, Maier K, Sander CA, et al. 2000. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192(10): 1441-52
33. Bryce PJ, Miller ML, Miyajima I, Tsai M, Galli SJ, et al. 2004. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 20(4):381-92
34. Thomas WR, Schrader JW. 1983. Delayed hypersensitivity in mast-cell-deficient mice. J. Immunol. 130(6): 2565-67
35. Galli SJ, Hammel I. 1984. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science 226(4675):710-13
36. d mice. J. Immunol. 135(2):879-85
37. Mekori YA, Weitzman GL, Galli SJ. 1985. Reevaluation of reserpine-induced suppression of contact sensitivity. Evidence that reserpine interferes with T lymphocyte function independently of an effect on mast cells. J. Exp. Med. 162(6):1935-53
38. v mice. Int. Arch. Allergy Appl. Immunol. 80(1):85-94
39. Secor VH, Secor WE, Gutekunst CA, Brown MA. 2000. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191(5):813-22
40. Mekori YA, Metcalfe DD. 2000. Mast cells in innate immunity. Immunol. Rev. 173:131-40
41. Chen R, Ning G, Zhao ML, Fleming MG, Diaz LA, et al. 2001. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J. Clin. Invest. 108(8):1151-58
42. Gurish MF, Austen KF. 2001. The diverse roles of mast cells. J. Exp. Med. 194(1):F1-5
43. Malaviya R, Abraham SN. 2001. Mast cell modulation of immune responses to bacteria. Immunol. Rev. 179:16-24
44. Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, et al. 2001. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413(6854):420-25
45. Benoist C, Mathis D. 2002. Mast cells in autoimmune disease. Nature 420(6917): 875-78
46. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, et al. 2002. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297(5587):1689-92
47. Pedotti R, De Voss JJ, Steinman L, Galli SJ. 2003. Involvement of both "allergic" and "autoimmune" mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24(9):479-84
48. Maurer M, Theoharides T, Granstein RD, Bischoff SC, Bienenstock J, et al. 2003. What is the physiological function of mast cells? Exp. Dermatol. 12(6):886-910
49. Galli SJ, Chatterjea D, Tsai M. 2004. Roles of mast cells and basophils in innate immunity. In The Innate Immune Response to Infection, ed. SHE Kaufman, R Medzhitov, S Gordon, pp. 111-32. Berlin: ASM Press
50. Theoharides TC, Conti P. 2004. Mast cells: the JEKYLL and HYDE of tumor growth. Trends Immunol. 25(5):235-41
51. Theoharides TC, Cochrane DE. 2004. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 146(1-2):1-12
52. Galli SJ, Maurer M, Lantz CS. 1999. Mast cells as sentinels of innate immunity. Curr. Opin. Immunol. 11(1):53-59
53. Wu JN, Jordan MS, Silverman MA, Peterson EJ, Koretzky GA. 2004. Differential requirement for adapter proteins Src homology 2 domain-containing leukocyte phosphoprotein of 76 kDa and adhesion- and degranulation-promoting adapter protein in FcεRI signaling and mast cell function. J. Immunol. 172(11): 6768-74
54. Yang Y, Li L, Wong GW, Krilis SA, Madhusudhan MS. et al. 2002. RasGRP4, a new mast cell-restricted Ras guanine nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs. Identification of defective variants of this signaling protein in asthma, mastocytosis, and mast cell leukemia patients and demonstration of the importance of RasGRP4 in mast cell development and function. J. Biol. Chem. 277(28):25756-74
55. Li L, Yang Y, Stevens RL. 2003. RasGRP4 regulates the expression of prostaglandin D2 in human and rat mast cell lines. J. Biol. Chem. 278(7):4725-29
56. Nadler MJ, Kinet JP. 2002. Uncovering new complexities in mast cell signaling. Nat. Immunol. 3(8):707-8
57. Heneberg P, Draber P. 2002. Nonreceptor protein tyrosine and lipid phosphatases in type I Fcε receptor-mediated activation of mast cells and basophils. Int. Arch. Allergy Immunol. 128(4):253-63
58. Kamata T, Yamashita M, Kimura M, Murata K, Inami M, et al. 2003. Src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation. J. Clin. Invest. 111(1):109-19
59. Rauh MJ, Kalesnikoff J, Hughes M, Sly L, Lam V, et al. 2003. Role of Src homology 2-containing-inositol 5′-phosphatase (SHIP) in mast cells and macrophages. Biochem. Soc. Trans. 31:286-91
60. Qu X, Sada K, Kyo S, Maeno K, Miah SM, et al. 2004. Negative regulation of FcεRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b. Blood 103(5):1779-86
61. Ota Y, Samelson LE. 1997. The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase. Science 276(5311):418-20
62. Odom S, Gomez G, Kovarova M, Furumoto Y, Ryan JJ, et al. 2004. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J. Exp. Med. 199(11):1491-502
63. Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. 2000. Understanding Ras: "It ain't over 'til it's over." Trends Cell Biol. 10(4):147-54
64. Tam S-Y, Tsai M, Snouwaert JN, Kalesnikoff J, Scherrer D, et al. 2004. RabGEF1 is a negative regulator of mast cell activation and skin inflammation. Nat. Immunol. 5:844-52
65. Gergely J, Pecht I, Sarmay G. 1999. Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells. Immunol. Lett. 68(1):3-15
66. Scharenberg AM. 1999. The inhibitory receptor superfamily: potential relevance to atopy. Curr. Opin. Immunol. 11(6):621-25
67. Katz HR. 2002. Inhibitory receptors and allergy. Curr. Opin. Immunol. 14(6): 698-704
68. Abramson J, Rozenblum G, Pecht I. 2003. Dok protein family members are involved in signaling mediated by the type I Fcε receptor. Eur. J. Immunol. 33(1):85-91
69. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV. 1996. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 379(6563):346-49
70. Zhu D, Kepley CL, Zhang M, Zhang K, Saxon A. 2002. A novel human immunoglobulin Fcγ Fcε bifunctional fusion protein inhibits FcεRI-mediated degranulation. Nat. Med. 8(5):518-21
71. Katz HR. 2002. Inhibition of anaphylactic inflammation by the gp49B1 receptor on mast cells. Mol. Immunol. 38(16-18):1301-5
72. Song J, Hagen G, Smith SM, Roess DA, Pecht I, et al. 2002. Interactions of the mast cell function-associated antigen with the type I Fcε receptor. Mol. Immunol. 38(16-18):1315-21
73. Lacy P, Logan MR, Bablitz B, Moqbel R. 2001 Fusion protein vesicle-associated membrane protein 2 is implicated in IFN-γ-induced piecemeal degranulation in human eosinophils from atopic individuals. J. Allergy Clin. Immunol. 107(4):671-78
74. Bandeira-Melo C, Woods LJ, Phoofolo M, Weller PF. 2002. Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion. J. Exp. Med. 196(6):841-50
75. Theoharides TC, Bondy PK, Tsakalos ND, Askenase PW. 1982. Differential release of serotonin and histamine from mast cells. Nature 297(5863):229-31
76. Leal-Berumen I, Conlon P, Marshall JS. 1994. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J. Immunol. 152(11):5468-76
77. Huber M, Helgason CD, Damen JE, Liu L, Humphries RK, Krystal G. 1998. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc. Natl. Acad. Sci. USA 95(19):11330-35
78. Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM. 1999. Syk deficiency in nonreleaser basophils. J. Allergy Clin. Immunol. 104:279-84
79. Vonakis BM, Gibbons S Jr, Sora R, Langdon JM, MacDonald SM. 2001. Src homology 2 domain-containing inositol 5′ phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils. J. Allergy Clin. Immunol. 108(5):822-31
80. Hsu C, MacGlashan D Jr. 1996. IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells. Immunol. Lett. 52(2-3):129-34
81. Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, et al. 1997. IgE enhances mouse mast cell FcεRI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J. Exp. Med. 185(4):663-72
82. Lantz CS, Yamaguchi M, Oettgen HC, Katona IM, Mijama I, et al. 1997. IgE regulates mouse basophil FcεRI expression in vivo. J. Immunol. 158(6):2517-21
83. Yamaguchi M, Sayama K, Yano K, Lantz CS, Noben-Trauth N, et al. 1999. IgE enhances Fcε receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fcε receptor I expression and mediator release. J. Immunol. 162(9):5455-65
84. MacGlashan D Jr, Xia HZ, Schwartz LB, Gong J. 2001. IgE-regulated loss, not IgE-regulated synthesis, controls expression of FcεRI in human basophils. J. Leukoc. Biol. 70(2):207-18
85. Kubo S, Matsuoka K, Taya C, Kitamura F, Takai T, et al. 2001. Drastic up-regulation of FcεRI on mast cells is induced by IgE binding through stabilization and accumulation of FcεRI on the cell surface. J. Immunol. 167(6):3427-34
86. Borkowski TA, Jouvin MH, Lin SY, Kinet JP. 2001. Minimal requirements for IgE-mediated regulation of surface FcεRI. J. Immunol. 167(3):1290-96
87. Saini SS, MacGlashan D. 2002. How IgE upregulates the allergic response. Curr. Opin. Immunol. 14(6):694-97
88. Kalesnikoff J, Huber M, Lam V, Damen JE, Zhang J, et al. 2001. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14(6):801-11
89. Kitaura J, Song J, Tsai M, Asai K, Maeda-Yamamoto M, et al. 2003. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcεRI. Proc. Natl. Acad. Sci. USA 100(22):12911-16
90. Tanaka S, Takasu Y, Mikura S, Satoh N, Ichikawa A. 2002. Antigen-independent induction of histamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells. J. Exp. Med. 196(2): 229-35
91. Asai K, Kitaura J, Kawakami Y, Yamagata N, Tsai M, et al. 2001. Regulation of mast cell survival by IgE. Immunity 14(6):791-800
92. James LC, Roversi P, Tawfik DS. 2003. Antibody multispecificity mediated by conformational diversity. Science 299(5611):1362-67
93. Marquardt DL, Parker CW, Sullivan TJ. 1978. Potentiation of mast cell mediator release by adenosine. J. Immunol. 120:871-88
94. Marquardt DL, Walker LL, Wasserman SI. 1986. Cromolyn inhibition of mediator release in mast cells derived from mouse bone marrow. Am. Rev. Respir. Dis. 113:1105-19
95. Laffargue M, Calvez R, Finan P, Trifillieff A, Barbier M, et al. 2002. Phosphoinositide 3-kinase γ is an essential amplifier of mast cell function. Immunity 16:441-51
96. Wymann MP, Bjorklof K, Calvez R, Finan P, Thomast M, et al. 2003. Phosphoinositide 3-kinase γ: a key modulator in inflammation and allergy. Biochem. Soc. Trans. 31(Pt. 1):275-80
97. Tilley SL, Wagoner VA, Salvatore CA, Jacobson MA, Koller BH. 2000. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J. Clin. Invest. 105:361-67
98. Okumura S, Kashiwakura J, Tomita H, Matsumoto K, Nakajima T, et al. 2003. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcεRI. Blood 102:2547-54
99. Stokes AJ, Shimoda LM, Koblan-Huberson M, Adra CN, Turner H. 2004. A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells. J. Exp. Med. 200(2):137-47
100. Gonzalez-Espinosa C, Odom S, Olivera A, Hobson JP, Martinez ME, et al. 2003. Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J. Exp. Med. 197(11):1453-65
101. Tsai M, Tam SY, Wedemeyer J, Galli SJ. 2002. Mast cells derived from embryonic stem cells: a model system for studying the effects of genetic manipulations on mast cell development, phenotype, and function in vitro and in vivo. Int. J. Hematol. 75(4):345-49
102. v mice and their increase by bone marrow transplantation. Blood 52(2):447-52
103. Stevens J, Loutit JF. 1982. Mast cells in spotted mutant mice (W Ph mi). Proc. R. Soc. London B Biol. Sci. 215(1200):405-9
104. Mallen-St Clair J, Pham CT, Villalta SA, Caughey GH, Wolters PJ. 2004. Mast cell dipeptidyl peptidase I mediates survival from sepsis. J. Clin. Invest. 113(4):628-34
105. W-sh mice as a model for investigating mast cell biology in vivo. FASEB J. (Abstr.) In press
106. Berrozpe G, Timokhina I, Yukl S, Tajima Y, Ono M, et al. 1999. The W(sh), W(57), and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit. Blood 94(8):2658-66
107. Duttlinger R, Manova K, Chu TY, Gyssler C, Zelenetz AD, et al. 1993. W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. Development 118(3):705-17
108. sh mice: age-dependent abolishment of c-kit gene expression. Blood 83(12):3509-16
109. Lantz CS, Boesiger J, Song CH, Mach N, Kobayashi T, et al. 1998. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392(6671):90-93
110. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, et al. 1999. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13(11):1382-97
111. v mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J. Exp. Med. 162(3):1025-43
112. Tsai M, Wedemeyer J, Ganiatsas S, Tam SY, Zon LI, et al. 2000. In vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo. Proc. Natl. Acad. Sci. USA 97(16):9186-90
113. Wershil BK, Furuta GT, Wang ZS, Galli SJ. 1996. Mast cell-dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology 110(5):1482-90
114. v mice that are genetically deficient in mast cells. J. Exp. Med. 165(3):615-27
115. Martin TR, Takeishi T, Katz HR, Austen KF, Drazen JM, et al. 1993. Mast cell activation enhances airway responsiveness to methacholine in the mouse. J. Clin. Invest. 91(3):1176-82
116. Williams CMM, Galli SJ. 2000. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med. 192(3):455-62
117. Tanzola MB, Robbie-Ryan M, Gutekunst CA, Brown MA. 2003. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171(8):4385-91
118. Lee YM, Jippo T, Kim DK, Katsu Y, Tsujino K, et al. 1998. Alteration of protease expression phenotype of mouse peritoneal mast cells by changing the microenvironment as demonstrated by in situ hybridization histochemistry. Am. J. Pathol. 153(3):931-36
119. Jippo T, Lee YM, Ge Y, Kim DK, Okabe M, et al. 2001. Tissue-dependent alteration of protease expression phenotype in murine peritoneal mast cells that were genetically labeled with green fluorescent protein. Am. J. Pathol. 158(5):1695-701
120. Du T, Friend DS, Austen KF, Katz HR. 1996. Tissue-dependent differences in the asynchronous appearance of mast cells in normal mice and in congenic mast cell-deficient mice after infusion of normal bone marrow cells. Clin. Exp. Immunol. 103(2):316-21
121. Jippo T, Morii E, Ito A, Kitamura Y. 2003. Effect of anatomical distribution of mast cells on their defense function against bacterial infections: demonstration using partially mast cell-deficient tg/tg mice. J. Exp. Med. 197(11):1417-25
122. Wershil BK, Tsai M, Geissler EN, Zsebo KM, Galli SJ. 1992. The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function. J. Exp. Med. 175(1): 245-55
123. Garrington TP, Ishizuka T, Papst PJ, Chayama K, Webb S, et al. 2000. MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells. EMBO J. 19(20): 5387-95
124. Maurer M, Wedemeyer J, Metz M, Piliponsky AM, Weller K, et al. 2004. Mast cells promote homeostasis by limiting endothelin-1 induced toxicity. Nature. 432:512-16
125. v mice. J. Parasitol. 70(5):767-73
126. v mice. Blood 69(6):1661-66
127. d genetically mast cell-deficient mice. Blood 75(8):1637-45
128. v mice allows the development of macroscopic hematopoietic spleen colonies and restores cutaneous mast cell number. J. Exp. Med. 172(1):403-6
129. Khan AI, Horii Y, Tiuria R, Sato Y, Nawa Y. 1993. Mucosal mast cells and the expulsive mechanisms of mice against Strongyloides venezitelensis. Int. J. Parasitol. 23(5):551-55
130. v mice. Int. Arch. Allergy Immunol. 102(4):352-61
131. Wershil BK, Mekori YA, Murakami T, Galli SJ. 1987. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J. Immunol. 139(8):2605-14
132. Wershil BK, Wang ZS, Gordon JR, Galli SJ. 1991. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J. Clin. Invest. 87(2):446-53
133. Martin TR, Galli SJ, Katona IM, Drazen JM. 1989. Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice. J. Clin. Invest. 83(4):1375-83
134. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP, et al. 1997. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J. Clin. Invest. 99(5):901-14
135. Takeishi T, Martin TR, Katona IM, Finkelman FD, Galli SJ. 1991. Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. Mast cells are not required for the cardiopulmonary changes associated with certain fatal anaphylactic responses. J. Clin. Invest. 88(2):598-608
136. Choi IH, Shin YM, Park JS, Lee MS, Han EH, et al. 1998. Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice. J. Exp. Med. 188(9):1587-92
137. Choi IW, Kim YS, Kim DK, Choi JH, Seo KH, et al. 2003. Platelet-activating factor-mediated NF-κB dependency of a late anaphylactic reaction. J. Exp. Med. 198(1):145-51
138. Strait RT, Morris SC, Yang M, Qu XW, Finkelman FD. 2002. Pathways of anaphylaxis in the mouse. J. Allergy Clin. Immunol. 109(4):658-68
139. Latour S, Bonnerot C, Fridman WH, Daeron M. 1992. Induction of tumor necrosis factor-α production by mast cells via FcγR. Role of the FcγRIII γ subunit. J. Immunol. 149(6):2155-62
140. Kobayashi T, Miura T, Haba T, Sato M, Serizawa I, et al. 2000. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J. Immunol. 164(7):3855-61
141. Kung TT, Stelts D, Zurcher JA, Jones H, Umland SP, et al. 1995. Mast cells modulate allergic pulmonary eosinophilia in mice. Am. J. Respir. Cell Mol. Biol. 12(4):404-9
142. Yu M, Tsai M, Tam S-Y, Galli SJ. 2005. Mast cells mediate multiple features of asthmatic responses in a mouse model of chronic asthma. J. Allergy Clin. Immunol. (Abstr.) In press
143. Masuda T, Tanaka H, Komai M, Nagao K, Ishizaki M, et al. 2003. Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma. Clin. Exp. Allergy 33(5):705-13
144. Kraneveld AD, van der Kleij HP, Kool M, van Houwelingen AH, Weitenberg AC, et al. 2002. Key role for mast cells in nonatopic asthma. J. Immunol. 169(4): 2044-53
145. Redegeld FA, van der Heijden MW, Kool M, Heijdra BM, Garssen J, et al. 2002. Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nat. Med. 8(7):694-701
146. Nogami M, Suko M, Okudaira H, Miyamoto T, Shiga J, et al. 1990. Experimental pulmonary eosinophilia in mice by Ascaris suum extract. Am. Rev. Respir. Dis. 141:1289-95
147. Okudaira H, Nogami M, Matsuzaki G, Dohi M, Suko M, et al. 1991. T-cell-dependent accumulation of eosinophils in the lung and its inhibition by monoclonal anti-interleukin-5. Int. Arch. Allergy Appl. Immunol. 94(1-4):171-73
148. Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cuvelier CA, et al. 1994. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin. Exp. Allergy 24(1):73-80
149. Takeda K, Hamelmann E, Joetham A, Shultz LD, Larsen GL, et al. 1997. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J. Exp. Med. 186(3):449-54
150. v mice against Strongyloides ratti infection and its reconstitution with bone marrow cells. Parasite Immunol. 7(4): 429-38
151. v mice by adoptive transfer of bone marrow-derived cultured mast cells and its effects on the protective capacity to Strongyloides ratti-infection. Parasite Immunol. 9(1):31-38
152. Matsuda H, Watanabe N, Kiso Y, Hirota S, Ushio H, et al. 1990. Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice. J. Immunol. 144(1):259-62
153. Wershil BK, Theodos CM, Galli SJ, Titus RG. 1994. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J. Immunol. 152(9):4563-71
154. Robbie-Ryan M, Tanzola MB, Secor VH, Brown MA. 2003. Cutting edge: Both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J. Immunol. 170(4):1630-34
155. Steeves EB, Allen JR. 1991. Tick resistance in mast cell-deficient mice: histological studies. Int. J. Parasitol. 21(2):265-68
156. Brown SJ, Galli SJ, Gleich GJ, Askenase PW. 1982. Ablation of immunity to Amblyomma americanum by anti-basophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs. J. Immunol. 129(2):790-96
157. Galli SJ, Askenase PW. 1986. Cutaneous basophil hypersensitivity. In The Reticuloendothelial System: A Comprehensive Treatise. Vol. IX: Hypersensitivity, ed. P Abramoff, SM Phillips, MR Escobar, pp. 321-69. New York: Plenum
158. Arizono N, Kasugai T, Yamada M, Okada M, Morimoto M, et al. 1993. Infection of Nippostrongylits brasiliensis induces development of mucosal-type but not connective tissue-type mast cells in genetically mast cell-deficient Ws/Ws rats. Blood 81(10):2572-78
159. Newlands GF, Miller HR, MacKellar A, Galli SJ. 1995. Stem cell factor contributes to intestinal mucosal mast cell hyperplasia in rats infected with Nippostrongylus brasiliensis or Trichinella spiralis, but anti-stem cell factor treatment decreases parasite egg production during N. brasiliensis infection. Blood 86(5):1968-76
160. Friedman MM, Kaliner MA. 1987. Human mast cells and asthma. Am. Rev. Respir. Dis. 135(5):1157-64
161. Smith TJ, Weis JH. 1996. Mucosal T cells and mast cells share common adhesion receptors. Immunol. Today 17(2):60-63
162. Dvorak HF, Mihm MC Jr, Dvorak AM. 1976. Morphology of delayed-type hyersensitivity reactions in man. J. Invest. Dermatol. 67:391-401
163. Razin E, Ihle JN, Seldin D, Mencia-Huerta JM, Katz HR, et al. 1984. Interleukin 3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J. Immunol. 132(3):1479-86
164. Alam R, Kumar D, Anderson-Walters D, Forsythe PA. 1994. Macrophage inflammatory protein-1α and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J. Immunol. 152(3):1298-303
165. Wang HW, Tedla N, Lloyd AR, Wakefield D, McNeil PH. 1998. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J. Clin. Invest. 102(8):1617-26
166. Frandji P, Oskeritzian C, Cacaraci F, Lapeyre J, Peronet R, et al. 1993. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151(11):6318-28
167. Fox CC, Jewell SD, Whitacre CC. 1994. Rat peritoneal mast cells present
168. Malaviya R, Ross EA, MacGregor JI, Ikeda T, Little JR, et al. 1994. Mast cell phagocytosis of FimH-expressing enterobacteria. J. Immunol. 152(4):1907-14
169. Malaviya R, Twesten NJ, Ross EA, Abraham SN, Pfeifer JD. 1996. Mast cells process bacterial Ags through a phagocytic route for class 1 MHC presentation to T cells. J. Immunol. 156(4):1490-96
170. Mecheri S, David B. 1997. Unravelling the mast cell dilemma: Culprit or victim of its generosity? Immunol. Today 18(5):212-15
171. Grabbe J, Karau L, Welker P, Ziegler A, Henz BM. 1997. Induction of MHC class II antigen expression on human HMC-1 mast cells. J. Dermatol. Sci. 16(1):67-73
172. Frandji P, Mourad W, Tkaczyk C, Singer M, David B, et al. 1998. IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class II-dependent signaling pathway. Eur. J. Immunol. 28(3):844-54
173. Dimitriadou V, Mecheri S, Koutsilieris M, Fraser W, Al-Daccak R, et al. 1998. Expression of functional major histocompatibility complex class II molecules on HMC-1 human mast cells. J. Leukoc. Biol. 64(6):791-99
174. + T lymphocyte chemoattractant factor, IL-16. J. Immunol. 159(6):2904-10
175. 4. Nat. Immunol. 4(10):974-81
176. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. 1991. Human dermal mast cells contain and release tumor necrosis factor a, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA 88(10):4220-24
177. Meng H, Marchese MJ, Garlick JA, Jelaska A, Korn JH, et al. 1995. Mast cells induce T-cell adhesion to human fibroblasts by regulating intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression. J. Invest. Dermatol. 105(6):789-96
178. Jutel M, Watanabe T, Akdis M, Blaser K, Akdis CA. 2002. Immune regulation by histamine. Curr. Opin. Immunol. 14(6):735-40
179. Inamura N, Mekori YA, Bhattacharyya SP, Bianchine PJ, Metcalfe DD. 1998. Induction and enhancement of FcεRI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. J. Immunol. 160(8):4026-33
180. Bhattacharyya SP, Drucker I, Reshef T, Kirshenbaum AS, Metcalfe DD, et al. 1998. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J. Leukoc. Biol. 63(3):337-41
181. Baram D, Vaday GG, Salamon P, Drucker I, Hershkoviz R, et al. 2001. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-α. J. Immunol. 167(7):4008-16
182. Sitia G, Isogawa M, Iannacone M, Campbell IL, Chisari FV, et al. 2004. MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J. Clin. Invest. 113(8):1158-67
183. Grabbe S, Schwarz T. 1998. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 19(1):37-44
184. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P. 1987. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J. Exp. Med. 166(6):1654-67
185. Steinman RM, Pack M, Inaba K. 1997. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156:25-37
186. Villa I, Skokos D, Tkaczyk C, Peronet R, David B, et al. 2001. Capacity of mouse mast cells to prime T cells and to induce specific antibody responses in vivo. Immunology 102(2):165-72
187. Ptak W, Geba GP, Askenase PW. 1991. Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine. J. Immunol. 146(11):3929-36
188. Jawat DM, Albert EJ, Rowden G, Haidl ID, Marshall JS. 2004. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J. Immunol. 173(8):5275-82
189. Hart PH, Grimbaldeston MA, Swift GJ, Jaksic A, Noonan FP, et al. 1998. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J. Exp. Med. 187(12):2045-53
190. Brain SD, Williams TJ. 1988. Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature 335(6185):73-75
191. Berger P, Perng DW, Thabrew H, Compton SJ, Cairns JA, et al. 2001. Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. J. Appl. Physiol. 91(3):1372-79
192. McLachlan JB, Hart JP, Pizzo SV, Shelburne CP, Staats HF, et al. 2003. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat. Immunol. 4(12):1199-205
193. Galli SJ, Nakae S. 2003. Mast cells to the defense. Nat. Immunol. 4(12):1160-62
194. Eager KB, Hackett CJ, Gerhard WU, Bennink J, Eisenlohr LC, et al. 1989. Murine cell lines stably expressing the influenza virus hemagglutinin gene introduced by a recombinant retrovirus vector are constitutive targets for MHC class I- and class II-restricted T lymphocytes. J. Immunol. 143(7):2328-35
195. Caron G, Delneste Y, Roelandts E, Duez C, Bonnefoy JY, et al. 2001. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J. Immunol. 167(7):3682-86
196. Stoitzner P, Ratzinger G, Koch F, Janke K, Scholler T, et al. 2001. Interleukin-16 supports the migration of Langerhans cells, partly in a CD4-independent way. J. Invest. Dermatol. 116(5):641-49
197. Cumberbatch M, Dearman RJ, Antonopoulos C, Groves RW, Kimber I. 2001. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-α- and IL-1β-dependent mechanism. Immunology 102(3):323-30
198. Kabashima K, Sakata D, Nagamachi M, Miyachi Y, Inaba K, et al. 2003. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9(6):744-49
199. Mekori YA, Metcalfe DD. 1999. Mast cell-T cell interactions. J. Allergy Clin. Immunol. 104:517-23
200. Brown MA, Tanzola MB, Robbie-Ryan M. 2002. Mechanisms underlying mast cell influence on EAE disease course. Mol. Immunol. 38(16-18):1373-78
201. Church MK, el-Lati S, Caulfield JP. 1991. Neuropeptide-induced secretion from human skin mast cells. Int. Arch. Allergy Appl. Immunol. 94(1-4):310-18
202. Varadaradjalou S, Feger F, Thieblemont N, Hamouda NB, Pleau JM, et al. 2003. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 33(4):899-906
203. Li L, Li Y, Reddel SW, Cherrian M, Friend DS, et al. 1998. Identification of basophilic cells that express mast cell granule proteases in the peripheral blood of asthma, allergy, and drug-reactive patients. J. Immunol. 161(9):5079-86
204. Di Nardo A, Vitiello A, Gallo RL. 2003. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170(5):2274-78
205. Weller PF, Tsai M, Galli SJ. 2003. Eosinophils, basophils, and mast cells. In Blood: Principles and Practice of Hematology, ed. RI Handin, SE Lux, TP Stossel TP, pp. 569-88. Philadelphia, PA: JB Lippincott. 2nd ed.